Results 31 to 40 of about 132,728 (352)

Candidacidal factors in murine bronchoalveolar lavage fluid [PDF]

open access: yesInfection and Immunity, 1987
Respiratory secretions provide an efficient method for protecting the large surface area of the lower respiratory tract. To determine whether lung secretions contribute to antifungal defenses, we tested bronchoalveolar lavage fluid for fungicidal activity.
K M, Nugent, R B, Fick
openaire   +2 more sources

Quantitative PCR (qPCR) Detection of Mucorales DNA in Bronchoalveolar Lavage Fluid To Diagnose Pulmonary Mucormycosis

open access: yesJournal of Clinical Microbiology, 2018
Early diagnosis and treatment are essential to improving the outcome of mucormycosis. The aim of this retrospective study was to assess the contribution of quantitative PCR detection of Mucorales DNA in bronchoalveolar lavage fluids for early diagnosis ...
E. Scherer   +13 more
semanticscholar   +1 more source

Diagnostic value of microRNAs derived from exosomes in bronchoalveolar lavage fluid of early‐stage lung adenocarcinoma: A pilot study

open access: yesThoracic Cancer, 2018
Low‐dose computed tomography can identify smaller nodules more often than chest radiography in lung screening. However, complications from invasive diagnostic procedures performed to detect nodules are common.
J. Kim   +9 more
semanticscholar   +1 more source

Two cases of primary human parechovirus pneumonia in adults

open access: yesRespiratory Medicine Case Reports, 2019
Human parechoviruses (HPeV) are mainly isolated from upper respiratory tract infection and gastroenteritis in children. HPeV has not been screened for in the past studies of community-acquired pneumonia (CAP) in adults, and its association with CAP is ...
Takashi Nishida   +6 more
doaj   +1 more source

Correlation of the lung microbiota with metabolic profiles in bronchoalveolar lavage fluid in HIV infection

open access: yesMicrobiome, 2016
BackgroundWhile 16S ribosomal RNA (rRNA) sequencing has been used to characterize the lung’s bacterial microbiota in human immunodeficiency virus (HIV)-infected individuals, taxonomic studies provide limited information on bacterial function and impact ...
S. Cribbs   +11 more
semanticscholar   +1 more source

The Antioxidant System of the Respiratory Tract Antioxidant Effectors in Supraepithelial and Extracellular Space (Part 1)

open access: yesZdorovʹe Rebenka, 2016
The review of literature presents the current data about the antioxidant system of the respiratory tract. The localization of the components and functioning of the enzyme link of antioxidant defense in the respiratory tract are described.
O.Ye. Abaturov   +2 more
doaj   +1 more source

β-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up

open access: yesRespiratory Research, 2011
Background β-thymosins play roles in cytoskeleton rearrangement, angiogenesis, fibrosis and reparative process, thus suggesting a possible involvement in the pathogenesis of systemic sclerosis.
Messana Irene   +14 more
doaj   +1 more source

Elevated peptides in lung lavage fluid associated with bronchiolitis obliterans syndrome. [PDF]

open access: yesPLoS ONE, 2014
The objective of this discovery-level investigation was to use mass spectrometry to identify low mass compounds in bronchoalveolar lavage fluid from lung transplant recipients that associate with bronchiolitis obliterans syndrome.Bronchoalveolar lavage ...
Matthew D Stone   +5 more
doaj   +1 more source

Electronic nose analysis of bronchoalveolar lavage fluid

open access: yesEuropean Journal of Clinical Investigation, 2010
Eur J Clin Invest 2010; 41 (1): 52–58AbstractBackground  Electronic nose (E‐nose) technology has been successfully used to diagnose a number of microbial infections. We have investigated the potential use of an E‐nose for the diagnosis of ventilator‐associated pneumonia (VAP) by detecting micro‐organisms in bronchoalveolar lavage (BAL) fluid in a ...
Humphreys, L   +8 more
openaire   +2 more sources

Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy

open access: yesAdvanced Materials, EarlyView.
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy